These anti-inflammatory fractions treat gouty arthritis by inhibiting the release of the inflammatory factors including prostaglandin E2 (PGE2) and TNF-α, which may relieve the symptoms of redness, fever and severe pain that occur during gout attacks (Zeng and Cen, 2012). This evidence concerns the gene TNF and gout.